305 related articles for article (PubMed ID: 6400672)
41. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
[TBL] [Abstract][Full Text] [Related]
42. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.
Berglund J
Acta Med Scand Suppl; 1988; 722():1-69. PubMed ID: 3163465
[TBL] [Abstract][Full Text] [Related]
43. Effect of antihypertensive treatment on progression of incipient diabetic nephropathy.
Christensen CK; Mogensen CE
Hypertension; 1985; 7(6 Pt 2):II109-13. PubMed ID: 3908317
[TBL] [Abstract][Full Text] [Related]
44. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
Lacourcière Y; Bélanger A; Godin C; Hallé JP; Ross S; Wright N; Marion J
Kidney Int; 2000 Aug; 58(2):762-9. PubMed ID: 10916100
[TBL] [Abstract][Full Text] [Related]
45. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
[TBL] [Abstract][Full Text] [Related]
46. The effect of antihypertensive treatment on kidney function in insulin-dependent (type I) diabetics with renal failure.
Zander E; Conde N; Heinke P; Zander G; Strese J; Gums G; Schulz B
Exp Clin Endocrinol; 1990 Feb; 95(1):70-6. PubMed ID: 2335182
[TBL] [Abstract][Full Text] [Related]
47. Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy.
Nielsen FS; Rossing P; Gall MA; Skøtt P; Smidt UM; Parving HH
Diabetes; 1997 Jul; 46(7):1182-8. PubMed ID: 9200654
[TBL] [Abstract][Full Text] [Related]
48. Remission and regression of diabetic nephropathy.
Hovind P; Tarnow L; Parving HH
Curr Hypertens Rep; 2004 Oct; 6(5):377-82. PubMed ID: 15341691
[TBL] [Abstract][Full Text] [Related]
49. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
Galle J; Schwedhelm E; Pinnetti S; Böger RH; Wanner C;
Nephrol Dial Transplant; 2008 Oct; 23(10):3174-83. PubMed ID: 18450829
[TBL] [Abstract][Full Text] [Related]
50. Incipient nephropathy in type 1 (insulin-dependent) diabetes.
Mathiesen ER; Oxenbøll B; Johansen K; Svendsen PA; Deckert T
Diabetologia; 1984 Jun; 26(6):406-10. PubMed ID: 6468791
[TBL] [Abstract][Full Text] [Related]
51. Antihypertensive treatment: long-term reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function.
Christensen CK; Mogensen CE
J Diabet Complications; 1987; 1(2):45-52. PubMed ID: 2969901
[TBL] [Abstract][Full Text] [Related]
52. [Effect of treatment of arterial hypertension on renal function in patients with imminent and overt diabetic nephropathy].
Czekalski S; Pynka S; Majkowska L; Andrysiak-Mamos E; Krzyzanowska-Swiniarska B
Pol Arch Med Wewn; 1994; 92 Spec No():60-9. PubMed ID: 7731901
[TBL] [Abstract][Full Text] [Related]
53. Impaired autoregulation of glomerular filtration rate in type 1 (insulin-dependent) diabetic patients with nephropathy.
Parving HH; Kastrup H; Smidt UM; Andersen AR; Feldt-Rasmussen B; Christiansen JS
Diabetologia; 1984 Dec; 27(6):547-52. PubMed ID: 6442240
[TBL] [Abstract][Full Text] [Related]
54. Pentoxifylline, total urinary protein excretion rate and arterial blood pressure in long-term insulin-dependent diabetic patients with overt nephropathy.
Solerte SB; Fioravanti M; Patti AL; Schifino N; Zanoletti MG; Inglese V; Ferrari E
Acta Diabetol Lat; 1987; 24(3):229-39. PubMed ID: 3687315
[TBL] [Abstract][Full Text] [Related]
55. Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy.
Andersen S; Jacobsen P; Tarnow L; Rossing P; Juhl TR; Parving HH
Nephrol Dial Transplant; 2003 Feb; 18(2):293-7. PubMed ID: 12543883
[TBL] [Abstract][Full Text] [Related]
56. Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.
Elving LD; Wetzels JF; van Lier HJ; de Nobel E; Berden JH
Diabetologia; 1994 Jun; 37(6):604-9. PubMed ID: 7926346
[TBL] [Abstract][Full Text] [Related]
57. Current therapeutic management of diabetic nephropathy.
Kohler SM; Krämer BK
Acta Diabetol; 1994 Sep; 31(3):119-25. PubMed ID: 7827347
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria.
Gambardella S; Frontoni S; Grazia Felici M; Spallone V; Gargiulo P; Morano S; Menzinger G
Am J Cardiol; 1990 May; 65(17):46H-50H. PubMed ID: 2330907
[TBL] [Abstract][Full Text] [Related]
59. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
[TBL] [Abstract][Full Text] [Related]
60. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
